Skip to main content

Table 7 Systemic vascular resistance index (dyn.s.cm−5)

From: Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study

 Terlipressin group (n = 50)Placebo group (n = 50)P value
Baseline2573.49 ± 829.262319.10 ± 762.350.1135
0 min2222.59 ± 1071.891134.29 ± 964.23< 0.0001*
10 min2324.29 ± 832.431437.53 ± 850.34< 0.0001*
20 min2406.47 ± 728.201548.14 ± 730.20< 0.0001*
30 min2429.03 ± 843.531628.11 ± 773.68< 0.0001*
40 min2438.24 ± 794.701630.09 ± 662.42< 0.0001*
50 min2406.25 ± 820.911625.31 ± 746.30< 0.0001*
60 min2438.09 ± 735.131575.05 ± 753.54< 0.0001*
  1. Baseline reading before skin incision
  2. Minutes after weaning from cardiopulmonary bypass
  3. Mean ± SD
  4. *P value is significant when P < 0.05